Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Pharmaceutical manufacturing stands on the shoulders of raw ingredient quality and knowledge about chemical profiles. ((2R,3R,4R)-3-(Benzoyloxy)-4-Fluoro-4-Methyl-5-Oxotetrahydrofuran-2-Yl)Methyl Benzoate, recognized under BP, EP, and USP Pharmacopeia standards, carries importance not just in synthesis but in ensuring the consistency of the final dose. The molecule stands out due to its distinctive structure: a benzoylated methyl benzoate resting on a fluorinated, methylated tetrahydrofuran core, flanked by both reactive and stabilizing groups. This complexity is not just chemical trivia. Everything about its handling, processing, and storage boils down to the interactions between its ester, fluoro, and oxo functionalities, right down to the crystalline or powdered allotrope that emerges from the final purification cycle. Industry treats physical characteristics—solid-state form, solubility in polar and nonpolar solvents, density values, and crystallinity—as non-negotiable checkpoints for qualifying each batch, not paperwork to be filed away.
In the practical world of a chemical warehouse, this compound turns up as dense white to off-white solids—anything from flaky sheets to fine, microcrystalline powder, or sometimes as larger, glimmering pearls that spill easily across a glass tray. The transition from one form to another, say from flakes to powder, points to shifts in synthesis parameters or subtle humidity leaks inside the storage room. Each form tells its own story about particle surface area, dissolution potential, and packaging requirements. The material is rarely, if ever, seen in liquid or solution form at room temperature; it remains stubbornly solid until under the right solvent conditions, key for maintaining purity during scale-up. Pharmaceutical operators—trained chemists or automation techs—prefer this tactile clarity, since identification by touch and sight always precedes the more expensive instrument work.
With a molecular formula of C20H17FO6, ((2R,3R,4R)-3-(Benzoyloxy)-4-Fluoro-4-Methyl-5-Oxotetrahydrofuran-2-Yl)Methyl Benzoate fits cleanly into the families of fluorinated heterocycles and aromatic esters, which are celebrated in medicinal chemistry for their balance between reactivity and stability. This structure means every batch carries a consistent set of peaks for NMR, IR, and MS analysis. Each functional group plays a specific role: the fluoro atom sits at the heart of the molecule’s unique reactivity, while methyl substitution modulates sterics and solubility. This molecular backbone keeps everything from the bulk density to the flow properties in check, especially when compressed into tablets or dissolved for injectable formulations.
Some facts anchor the safe use and certification of this compound. Melting points consistently appear between tightly set temperature brackets, critical for GMP compliance. Density, typically in the range of 1.25 to 1.35 g/cm³, affects both weighing accuracy and shipping choices. Specification sheets detail everything from purity (often no less than 98.5% by HPLC), water content by Karl Fischer titration, residual solvents tested down to parts per million, heavy metals content well below ICH thresholds, and particle size distributions measured to prevent processing mishaps. The physical feel—firm crystals versus loose powder—signals handling needs and risk of air dispersal, which ties closely with occupational hygiene in chemical plants. Each batch batch carries its HS Code, internationally recognized, such as 29163900, earmarking its journey through customs and safety nets worldwide.
Hazard communication stays paramount for compounds in this chemical class. Despite its value as a medical raw material, ((2R,3R,4R)-3-(Benzoyloxy)-4-Fluoro-4-Methyl-5-Oxotetrahydrofuran-2-Yl)Methyl Benzoate, like most analogous intermediates, should not be taken lightly. Precautionary handling reflects the same respect given to other lightly volatile, structurally complex reagents: dust inhalation avoidance, spill management using filtered vacuum tools, storage in tightly sealed, non-reactive containers. SDS documentation sounds firm warnings: skin and eye contact causes irritation; ingestion or unintentional inhalation poses health risks; fire and decomposition produce hazardous vapors, including phenyl and fluoro-organic fragments. In a production environment, labeling and PPE become routine rituals, not bureaucratic obstacles. The discussion moves far beyond compliance, centering on worker safety, spill resilience, and emergency response clarity.
Seeing this compound only as a code or formula on a receipt misses the lived reality of chemical manufacturing. High-value, high-purity raw materials crisscross the globe daily, and ((2R,3R,4R)-3-(Benzoyloxy)-4-Fluoro-4-Methyl-5-Oxotetrahydrofuran-2-Yl)Methyl Benzoate claims special status due to its role in synthesizing complicated active pharmaceutical ingredients (APIs). Only rigorous control—material certificates, retesting, cross-batch verification—prevents catastrophic missteps: contamination brought by residual reactants or solvents, overlooked polymorph transitions, or loss of critical batch information. Material identity has weight: knowing that a compound will perform day after day, analysis after analysis, means stability in drug pipelines, reliability during audits, and—ultimately—patient safety at the center of everything. End-to-end traceability, from the raw benzoic acid precursor to the final pharma-grade flakes, becomes the invisible backbone of every certified shipment.
Chengguan District, Lanzhou, Gansu, China
